Bio-Rad Laboratories, Inc. (BIO-B)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
| Previous close | 279.91 |
| Open | 281.55 |
| Bid | 0.00 x 1400 |
| Ask | 0.00 x 800 |
| Day's range | 279.91 - 281.55 |
| 52-week range | 271.00 - 387.55 |
| Volume | |
| Avg. volume | 275 |
| Market cap | 7.71B |
| Beta (5Y monthly) | 0.94 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -10.69 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksBio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down
Bio-Rad's (BIO) Clinical Diagnostics arm registers growth in Q1, primarily driven by an increased demand for quality control, blood typing, and diabetes products.
Insider MonkeyBio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript May 7, 2024 Bio-Rad Laboratories, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon everyone, and welcome to today’s Bio-Rad First Quarter 2024 Earnings Results Conference Call. At this […]
- Thomson Reuters StreetEvents
Q1 2024 Bio Rad Laboratories Inc Earnings Call
Q1 2024 Bio Rad Laboratories Inc Earnings Call
© 2024 Yahoo. All rights reserved.